Azelnidipine

Ankleshwar, India Founded: 2016 • Age: 10 yrs
Produces high-quality APIs and pharmaceutical intermediates for the industry.
Annual revenue $3.5M Latest available
Total funding - Funding intelligence
Employees 58 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Azelnidipine

Azelnidipine is a company based in Ankleshwar (India) founded in 2016. It operates as a B2B. The company has 58 employees as of March 31, 2023. Azelnidipine operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Ankleshwar, India
  • Employees 58 as on 31 Mar, 2023
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Pure Chem Pvt. Ltd
  • Date of Incorporation 07 Apr, 1995
  • Jurisdiction Ankleshwar, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.54 M (USD)
    -11.22
    as on Mar 31, 2023
  • Net Profit
    $177.36 K (USD)
    -20.13
    as on Mar 31, 2023
  • EBITDA
    $535.9 K (USD)
    30.11
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    58

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Azelnidipine

Premium access

Detailed funding history for Azelnidipine

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Azelnidipine

Investments
Premium access

Investment portfolio details for Azelnidipine

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Azelnidipine

Premium access

Detailed financials for Azelnidipine

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Azelnidipine Comparisons

Azelnidipine Primary company
Description
Produces high-quality APIs and pharmaceutical intermediates ...
Location
Ankleshwar, India
Founded Year
2016
Annual Revenue
$3.54 M (USD)
Net Profit
$177.36 K (USD)
EBITDA
$535.9 K (USD)
Employees
58
As of 2023
Premium access

Peer comparison for Azelnidipine

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Azelnidipine

Azelnidipine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical and biotechnology company
Locked Locked Locked
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
Locked Locked Locked
APIs and drug products are developed and valorized in pharmaceuticals.
Locked Locked Locked
APIs, intermediates, and biochemical reagents are developed and manufactured.
Locked Locked Locked
APIs are developed and manufactured for therapeutic areas.
Locked Locked Locked
Contract development, manufacturing, and analytical services for APIs are offered.
Premium access

Detailed competitors of Azelnidipine

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Azelnidipine

Premium access

Complete news archive for Azelnidipine

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Azelnidipine

Azelnidipine was founded in 2016.

Azelnidipine is headquartered in Ankleshwar, India. It is registered at Ankleshwar, Gujarat, India.

As of Mar 31, 2023, the latest employee count at Azelnidipine is 58.

Annual revenue of Azelnidipine is $3.54M as on Mar 31, 2023.

Azelnidipine, established in 2016, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and intermediates. Produces high-quality APIs and pharmaceutical intermediates for the industry. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Azelnidipine's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available